Navigation Links
Joint replacement surgery riskier at hospitals with low surgical volume
Date:6/6/2011

Patients who undergo elective total hip or total knee arthroplasty at hospitals with lower surgical volume had a higher risk of venous thromboembolism and mortality following the procedure. The complications following joint replacement surgery at low-volume sites may be reduced by modifying systems and procedures used before and after surgery according to the findings published today in Arthritis & Rheumatism, a peer-reviewed journal of the American College of Rheumatology (ACR).

The ACR estimates that 27 million Americans over the age of 25 have doctor-diagnosed osteoarthritis and another 1.3 million US adults suffer with rheumatoid arthritis. For patients with end-stage hip and knee arthritis, total hip and knee arthroplasty are highly successful surgical interventions that offer patients significant improvement in pain, function and health-related quality of life. According to the Centers for Disease Control and Prevention (CDC) National Hospital Discharge Survey, roughly 230,000 total hip replacements and 543,000 total knee replacements were performed in the U.S. in 2007.

The current study explored the relationship between hospital procedure volume and surgical outcomes following primary total hip or total knee replacements. "With the large number of elective arthroplasty in the U.S, it is important to understand the impact of peri- and post-operative medical complications on the success of joint replacement surgery," said lead author Jasvinder Singh, MD, MPH of the University of Alabama. "Possible cardiac complications, blood clots, or infections increase patient morbidity and mortality risk, which can lead to higher health care utilization and costs."

Researchers used the Pennsylvania Health Care Cost Containment Council database to identify the number of patients who underwent total hip replacement (n=10,187) and total knee replacement (n=19,418) surgery in 2002 in the state. The mean age of patients in both groups was 69 years, and men comprised 43% of the total hip replacement cohort and 35% of the total knee replacement group. Hospital volume was categorized by less than 25 surgeries, 26-100, 101-200 (low-volume hospitals), and greater than 200 surgeries (high-volume hospitals) performed annually.

The findings show that patients who had primary total hip arthroplasty at low-volume hospitals were more likely to develop a pulmonary embolism (within 30 days of surgery) than those who had surgery at a high-volume hospital. One-year mortality was also higher for patients having total hip replacements at low-volume hospitals.

Researchers found that for total knee arthroplasty, patients age 65 and older had significantly higher odds for one-year mortality when surgeries were performed at low-volume hospitals compared to higher volume hospitals.

The authors theorize that the causes of complications at low-volume hospitals could be connected to hospital procedures and peri- and post-operative care processes. One example cited is differences in the selection of the best medication and device used to prevent blood clots following elective joint replacement surgery. The authors also suggest that the outcome of surgery is impacted by time of initiation and cessation of the clot prevention therapy. Dr. Singh concluded, "Further studies are needed to investigate whether the underlying reasons for poor surgical outcomes at low-volume hospitals are modifiable and which interventions may reduce complications for patients at these facilities."


'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Related medicine news :

1. CustomerCentric Selling and Kadient Announce Joint Event in Boston to Launch Strategic Partnership for Sales Enablement and Improvement
2. SNMs Conjoint Mid-Winter Meetings continue to advance molecular imaging
3. Major milestone achieved by our joint venture in China
4. Tufts Medical Center and Boston Medical Center Nurses Hold a Joint Informational Picket to Protest Unsafe Staffing and Practice Conditions
5. Orthopaedic Physician Dr. Brett Smith Joins Baptist Health Care as Total Joint Specialist
6. MIT China joint venture is preparing a major commercial launch in July 2010
7. Forest City Announces Joint Venture with Health Care REIT for University Park Life Science Properties
8. NIH-FDA Joint Briefing on Regulatory Science Collaboration
9. Acupuncture may relieve joint pain caused by some breast cancer treatments
10. ADD Insights, LLC and The New England ADHD Treatment Center Announce a Joint Seminar Series: Mastering One's ADHD
11. Patient and doctor expectations from joint replacement surgeries not always aligned
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... Head Island, SC (PRWEB) , ... February 08, 2016 , ... ... and surrounding areas with a vital new community enrichment program, has teamed up with ... local women and children suffering from intimate abuse. To support all those victimized by ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... relationship-marketing firm, announced today that nominations will be accepted February 8, 2016 ... Awards. , Awards include the Information Security Executive® of the Year, ...
(Date:2/8/2016)... ... ... Discover the Rocky Mountain region’s longest running and impressive garden and home show ... to see the most incredible gardens and home improvement experts that attend this amazing ... Center - 700 14th St. Denver CO, is an exciting event that Performance Mobility ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... speaking on how healthcare companies can use newly released government data on populations ... a population and intervene and capture the value they create to succeed in ...
(Date:2/7/2016)... , ... February 07, 2016 , ... ... with the latest techniques and the most minimally invasive approaches. , Women who ... particularly after menopause. Other risk factors include surgery to the pelvic floor, connective ...
Breaking Medicine News(10 mins):
(Date:2/8/2016)... N.J. , Feb. 8, 2016  Otsuka Pharmaceutical ... announced that they have entered into a licensing agreement ... in the U.S. and Puerto Rico ... a topical, non-steroidal phosphodiesterase IV (PDE-4) inhibitor, a new ... --> In a Phase II clinical ...
(Date:2/8/2016)... LAWRENCEVILLE, N.J. , Feb. 8, 2016   ... for healthcare professionals to guide them through GS1 Standards ... and Drug Administration (FDA) Unique Device Identification (UDI) rule. ... standards, GS1 US; Beth Gibson , senior director ... Roberts , industry development director, GS1 US ...
(Date:2/8/2016)... MEMPHIS, Tenn. , Feb. 8, 2016  A ... Hospital scientists has discovered details of how the ... cells triggers a particularly aggressive form of acute lymphoblastic ... cells, in which genetic mutations trigger overproduction of immature ... --> The discoveries of the malfunction underlying the ...
Breaking Medicine Technology: